Enter assignee name

EPO Patents = 4

Forward Citations = 25

Loading Chart...

12 inventors (with patents filed for the assignee):

Avinoam Kadouri (4 out of 6 patents)

Avihay Bar-Ilan (4 out of 5 patents)

Eldad Melamed (4 out of 24 patents)

4. Ofer Sadan (4 out of 5 patents)

5. Merav Bahat-Stromza (4 out of 8 patents)

6. Daniel Offen (4 out of 23 patents)

7. Yael Gothelf (3 out of 3 patents)

8. Yosef Levy (2 out of 2 patents)

9. Alex Burshtein (1 out of 1 patent)

10. Jonathan Semo (1 out of 1 patent)

11. Haggai Kaspi (1 out of 1 patent)

12. Revital Aricha (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 12233092 - MSC-NTF specific exosomes and use thereof (2025-02-25),

2. 10564149 - Populations of mesenchymal stem cells that secrete neurotrophic factors (2020-02-18),

3. 10052363 - Mesenchymal stem cells for the treatment of CNS diseases (2018-08-21),

4. 10046010 - Methods of generating mesenchymal stem cells which secrete neurotrophic factors (2018-08-14),

5. 9474787 - Mesenchymal stem cells for the treatment of CNS diseases (2016-10-25),

6. 8900574 - Mesenchymal stem cells for the treatment of CNS diseases (2014-12-02),

7. 8663987 - Mesenchymal stem cells for the treatment of CNS diseases (2014-03-04),

BrainStorm Cell Therapeutics Ltd. is a biotechnology company focused on developing innovative adult stem cell therapies for neurodegenerative diseases such as ALS and multiple sclerosis. Their lead product candidate, NurOwn, is currently in Phase 3 clinical trials and has shown promising results in early studies. With a strong commitment to research and development, BrainStorm aims to provide new treatment options for patients with debilitating neurological disorders.

Profile summary based on public USPTO records.